Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin

Cancer

Volumn 78, Issue 10, 1996, Pages 2193-2198

  Kris, Mark G ^a,f   Cubeddu, Luigi X ^b   Gralla, Richard J ^c   Cupissol, Didier ^d   Tyson, Leslie B ^a   Venkatraman, Ennpadam ^a   Homesley, Howard D ^e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c Ochsner Cancer Institute   (United States)

^d Lab d'Oncopharmacologie pharmacie Ctr Regl Lutte contre le Cancer V   (France)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

antiemetics; cisplatin; granisetron; metoclopramide; ondansetron; placebo; vomiting

Indexed keywords

ANTIEMETIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GRANISETRON; METOCLOPRAMIDE; MITOMYCIN; ONDANSETRON; PLACEBO; VINDESINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESEARCH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESEARCH; DRUG SCREENING; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; DOUBLE-BLIND METHOD; FEMALE; GRANISETRON; HUMANS; MALE; METOCLOPRAMIDE; MIDDLE AGED; ONDANSETRON; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; VOMITING;

EID: 0029861637     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961115)78:10<2193::AID-CNCR22>3.0.CO;2-T     Document Type: Article

References (24)

1. Gralla RJ, Itri LM, Pisko SE, Squillante AE, Kelsen DP, Braun DW. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981; 305(16):905-9.
2. Strum SB, McDermed JE, Opfell RW, Riech LP. Intravenous metoclopramide an effective antiemetic in cancer chemotherapy. JAMA 1982; 247:2683-6.
3. Homesley HD, Gainey JM, Jobson VW, Welander CE, Muss HB, Wells HB. Cisplatin chemotherapy and emesis in patients given metoclopramide and controls. N Engl J Med 1982; 307:250.
4. Kris MG, Gralla RJ, Clark RA, Tyson LB. Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy. J Clin Oncol 1988; 6:659-62.
5. Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting [see comments]. N Engl J Med 1990; 322:810-6.
6. Marty M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N, et al. Comparison of the 5-hydroxytryptamine 3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 1990; 322:816-21.
7. Hainsworth J, Harvey W, Pendergrass K, Kasimis B, Oblon D, Monaghan G, et al. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. J Clin Oncol 1991; 9:721-8.
8. Cupissol DR, Serrou B, Caubel M. The efficacy of granisetron as a prophylactic antie-emetic and intervention agent in high-dose cisplatin-induced emesis. Eur J Cancer 1990; 26:S23-7.
9. Navari RM, Kaplan HG, Gralla RJ, Grunberg SM, Palmer R, Fitts D. Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin. J Clin Oncol 1994; 12:2204-10.
10. Cassileth PA, Lusk EJ, Torri S, DiNubile N, Gerson SL. Anti-emetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med 1983; 143(7):1347-9.
11. Aapro MS, Plezia PM, Alberts DS, Graham V, Jones SE, Surwit EA, et al. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide. J Clin Oncol 1984; 2:466-71.
12. Markman M, Sheidler V, Ettinger DS, Quaskey SA, Mellits ED. Antiemetic efficacy of dexamethasone. Randomized double-blind crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med 1984; 311(9):549-52.
13. Frytak S, Moertel CG, O'Fallon JR, Rubin J, Creagan ET, O'Connell MJ, et al. Delta-9-Tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. Ann Intern Med 1979; 91:825-30.
14. Sallan SE, Zinberg NE, Frei E III. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 1975; 293(16):795-7.
15. Kris MG, Gralla RJ, Clark RA, Tyson LB, Groshen S. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. Cancer 1987; 60:2816-22.
16. Roila F, Tonato M, Cognetti F, Cortesi E, Favalli G, Marangolo M, et al. Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991; 9:675-8.
17. Roila F. Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 1995; 332:1-5.
18. CFR. Code of Federal Regulations. Food and Drugs. NDA Regulations. Part 314. Revised April 1, 1992. 314.126(V).1992.
19. Hays H. Antiemetic efficacy of metoclopramide. N Engl J Med 1982; 306(8):485-6.
20. Roila F, Tonato M, Del Favero A. Publication of unethical studies on the treatment of chemotherapy-induced emesis [letter]. J Clin Oncol 1991; 9(5):891-3.
21. Citron ML. Placebos and principles:a trial of ondansetron. Ann Intern Med 1993; 118(6):470-1.
22. Hait W. Ondansetron and cisplatin-induced nausea and vomiting. N Engl J Med 1990; 323:1485-6.
23. Ondansetron and cisplatin-induced nausea and vomiting [editorial]. N Engl J Med 1990; 323:1486.
24. Cubeddu LX, Hoffman IS, Fuenmayor NT, Finn AL. Use of placebo antiemetics, [reply]. N Engl J Med 1990; 323:1486.